Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Exclusive Q&A with Pharmacovigilance Expert at Pharmacovigilance, Drug Safety & Risk Management 2015SMi’s 4th annual Pharmacovigilance, Drug Safety & Risk Management conference takes place in just 4 weeks’ time on the 11th – 12th May 2015 at the Holiday Inn Regents Park Hotel in London, UK.
By: SMi Group Ltd This years summit includes 17 industry led presentations, 17 hours of compelling content, 1 topical panel, 5 hours of networking and 2 interactive workshops. Case studies will include a presentation by Bluefish Pharmaceuticals, Head of Pharmacovigilance and QPPV, Dr Julia Appelskog. "During my presentation I will provide practical examples of how to address various issues and what are the expectations from inspectors." Dr Appelskog quoted the PRAC keynote address by Doris Irene Stenver as one of the highlights of the show. "Doris is an excellent presenter and I am genially interested in the topic of internationalization...I am surprise to see how little information is available within the PV field and how much work is initiated within the Regulatory network. We need to have more information on the international cooperation such as ICH, ICMRA, IPRF, IGDRP, TTIP." The full interview is available to read in the event download centre at www.pharmacovigilance- The keynote address by Doris Stenver will discuss the latest PRAC updates and signal management processes in the UK. "I am Chief Medical Officer at the Danish Health and Medicines Authority and member of the Pharmacovigilance Risk Assessment Committee (PRAC); I am invited to give an update on activities in the PRAC, where I will focus on developments within risk management and risk minimization, signal management and communication" Other featured speakers include: • Graeme Ladds, CEO, Director of Operations, Pharmacovigilance, PharSafer Associates • Dr. Pipasha Biswas, Executive Director & QPPV, Symogen • Dr Kashif Sheikh, Senior Safety Surveillance Advisor, Novo Nordisk • Dr. Michael Merz, Chair Investigative Liver Expert Team, Novartis Institute for Biomedical Research • Shelley Gandhi, Director of Pharmacovigilance and Drug Safety, NDA Group Visit the website to see the full speaker line-up for 2015 Further information and a brochure is available online at www.pharmacovigilance- Pharmacovigilance, Drug Safety & Risk Management 11-12 May 2015 Holiday Inn Regents Park Hotel, London UK www.pharmacovigilance- ---END--- About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|